For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Build Your Order Apply for Wholesale
Build Your Order Products For Clinics For Pharmacies For Brands Quality Wholesale Resources About Contact Apply for Wholesale
Product sourcing reference

Melanotan I

Melanotan I is the research name for the afamelanotide sequence. An approved implant exists; research-grade material is a different product.

Reference variants

Add Melanotan I to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • 10mgVial · confirm physical formCAS 75921-69-6
    $7.19/vialCloseout estimate Regular $14.38. Subject to confirmation; not a stock promise.
    vials, packs of 10

Review your order request · Compare the full catalog

Confirm the exact substance

Afamelanotide is approved as a specific implant for a rare photosensitivity disorder. That approval does not cover vials sold under the Melanotan I name.

What the review will ask

The reference lists a closeout estimate. Treat the figure as subject to confirmation and review the intended use before requesting.

  • State the facility type, destination state and intended transaction. Do not send patient information.
  • Expect product- and lot-specific documentation to be requested before any material is accepted.
  • A listed price is a reference estimate. Availability, labeling, shipping and terms are confirmed in writing only after review.

Purchasing questions

Is Melanotan I the same as Melanotan II?

No. They differ in structure and receptor selectivity. Melanotan II has no approved product.

Keep implant documentation separate from vial references

The product presentation is part of its identity. A document about an afamelanotide implant does not establish the formulation, handling or authorization of a Melanotan I vial.

Documentation to request

Obtain the actual proposed product label and manufacturer. Do not substitute a different presentation's approval record.

Regulatory context: FDA: compounding, approval and quality standards. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Product-by-product review for hormone clinics. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. This reference is not medical or legal advice and does not establish a lawful supply route.

Discuss sourcing requirements
Call Apply for Wholesale